Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1Phase 2 Interventional

I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation

ClinicalTrials.gov ID: NCT00802347

Public ClinicalTrials.gov record NCT00802347. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 2:21 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation

Study identification

NCT ID
NCT00802347
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
Quark Pharmaceuticals
Industry
Enrollment
374 participants

Conditions and interventions

Interventions

  • I5NP Drug
  • Saline Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2008
Primary completion
Oct 31, 2013
Completion
Apr 30, 2014
Last update posted
Sep 17, 2014

2008 – 2014

United States locations

U.S. sites
33
U.S. states
16
U.S. cities
25
Facility City State ZIP Site status
University of Alabama Birmingham Birmingham Alabama 35294
Loma Linda University Medical Center Loma Linda California 92354
University of Southern California Los Angeles California 90033
Cedars-Sinai Medical Center Los Angeles California 90048
Transplant Research Institute (TRI; formerly NIT) Los Angeles California 90057
UCLA Medical Center Los Angeles California 90095
UC Davis Medical Center Sacramento California 95817
California Pacific Medical Center San Francisco California 94115
UCSF Medical Center San Francisco California 94143
University of Colorado Health Science Center Aurora Colorado 80045
Washington Hospital Center Washington D.C. District of Columbia 20010
University of Florida Gainesville Florida 32610
University of Miami Miami Florida 33136
Lifelink Healthcare Institute Tampa Florida 33606
Piedmont Hospital Atlanta Georgia 30309
Emory University Atlanta Georgia 30322
Rush University Chicago Illinois 60612
University of Illinois Chicago Chicago Illinois 60612
University of Maryland Baltimore Maryland 21201
Johns Hopkins University Baltimore Maryland 21205
University of Michigan Ann Arbor Michigan 48109
Mayo Clinic Rochester Rochester Minnesota 55905
Saint Barnabas Medical Center Livingston New Jersey 07039
Columbia University New York New York 10032
Cornell University New York New York 10065
Duke University Durham North Carolina 27710
Wake Forest University Medical Center Winston-Salem North Carolina 27157
Medical University of South Carolina Charleston South Carolina 29425
Baylor University Medical Center Dallas Texas 75246
Baylor All Saints Medical Center Fort Worth Texas 76104
The Methodist Hospital Houston Texas 77030
University of Virginia Charlottesville Virginia 22908
Virginia Commonwealth University (MCV) Richmond Virginia 23298

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 17 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00802347, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 17, 2014 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00802347 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →